Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial ...Middle East

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety Disorder Phase 2 clinical trial on target to start by end of 2021 and expected to read out topline data by end of 2022 ADELAIDE, Australia, Sept....

Hence then, the article about bionomics prepares bnc210 for start of phase 2 acute treatment of social anxiety disorder trial was published today ( Monday 20/09/2021 - 01:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial )

Also on site :

• 90 Years Later, the World's Most Famous Photo Exposes the Dark Side of Viral Fame: 'I Wish She Hadn't Taken My Picture'
• ‘We have to be able to walk and chew gum’ on government spending, says budget chairman on debt crisis and national security
• Businessman sues British Airways for £50k claiming cut finger caused ‘nightmares and flashbacks’